GLYCOMET GP 1

1. All Details: Specifications
Dosage Form: Uncoated prolonged-release tablets.
Storage Conditions: Protect from moisture and excessive heat. Keep out of the reach of children.
Batch Number (BATCH No.): 60002707
Manufacturing Date (MFG. DATE): 02/2026
Expiry Date (EXPIRY DATE): 01/2028
Manufacturing License Number: Mfg. Lic. No.: G/25/2569
Maximum Retail Price (M.R.P.): Rs. 123.28 per 15 tablets (Inclusive of all taxes).
Internal Material Identifiers: 3016569 06/22
2. General
Brand: Glycomet®-GP 1 (also printed in Devanagari script as ग्लाइकोमेट-जीपी १).
Name: Metformin Hydrochloride Prolonged-Release and Glimepiride Tablets IP
Quantity: 15 Tablets (indicated by “15 Tablets” and “FOR 15 TABS.”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the statutory red caution warning boxes for Schedule G and Schedule H).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: 23 months (from February 2026 to January 2028).
Food Preference / FSSAI: Not Applicable. This is a critical pharmaceutical prescription medication for managing chronic metabolic conditions, not a food product or dietary supplement. It falls under national drug regulation authorities rather than the FSSAI food authority, and it does not display vegetarian or non-vegetarian preference icons.
3. Product Details: Ingredients
Each uncoated tablet contains:
Metformin Hydrochloride IP (As prolonged-release): 500 mg
Glimepiride IP: 1 mg
Excipients: q.s. (Quantity Sufficient)
Colour: Red Oxide of Iron
4. Directions: How to Use
Dosage: As directed by the Physician.
Statutory Warning Labels:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under Medical Supervision.
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: Glycomet-GP 1 is a fixed-dose combination anti-diabetic medication. It combines an insulin-sensitizing biguanide (Metformin Hydrochloride in a prolonged-release mechanism) with an insulin-secreting sulfonylurea (Glimepiride). It is prescribed under strict medical supervision for blood sugar management in individuals diagnosed with Type 2 diabetes mellitus.
Visual Presentation: The packaging features a protective metallic blister backing with dual red cautionary notification blocks to signal its prescription-only status, as well as a scannable QR code for authenticity tracking.
6. Manufacturer Information
Mfd. by: USV Private Limited
Factory Address: Plot No. 538 to 540, 597 to 618, 619 to 625, GIDC Indl. Area-Savli, Taluka-Savli, Manjusar, Vadodara – 391 775.
7. Marketed By
Marketed By: USV Private Limited